() and potentially () health technologies which respond to unmet or priorityhealthcare needs in the local Philippine context may also be submitted for HTAC appraisal byrelevantindustries with the required clinical, social and economic evidence.  For existing health technologies, a () may be triggered by the emergenceof newclinical evidence that may have an impact on the previous recommendation of HTAC.